Mechanistically, YAP/TAZ have been shown to inhibit Wnt/-catenin signaling by inhibition of DVL nuclear translocation or induction of secreted Wnt inhibitors such as DKK1 and Wnt5a/b (Barry et al., 2013; Park et al., 2015; Seo et al., 2013; Varelas et al., 2010a). Hippo pathway parts in resulted in dramatic cells overgrowth phenotype that was later on recapitulated in transgenic mouse models (Dong et al., 2007; Harvey et al., 2003; Huang et al., 2005; Wu et al., 2003; Xu et al., 1995). Recent advances in recognition of the mammalian Hippo pathway parts and practical implications highlight the part of Hippo pathway in organ development, tumorigenesis, cells regeneration and stem cell self-renewal (Park and Guan 2013; Yu et al., 2015; Zanconato et al., 2016). The core Hippo SIGLEC7 pathway parts include a cytoplasmic kinase module and a nuclear transcriptional module. The kinase module is composed of mammalian STE20-like protein kinase 1 (MST1) and MST2, which phosphorylate and activate downstream kinases, large tumor suppressor 1 (LATS1) and LATS2. Recent studies show the MAP4K family as part of the kinase module parallel to MST1/2 by directly phosphorylating LATS (Meng et al., 2015). The major function of the Hippo kinase cascade is definitely to inhibit the oncogenic transcriptional module composed of yes-associated protein (YAP), transcriptional co-activator with PDZ-binding motif (TAZ), and TEA website family members (TEAD). YAP/TAZ function as transcriptional co-activators, which translocate between the cytoplasm and the nucleus, and induce target gene expression involved in cell proliferation and anti-apoptosis via connection with the TEAD family of transcription factors. Genetic evidence in mice demonstrates YAP and IQ-1S TAZ (two homologs of Yorkie) are functionally redundant during IQ-1S development and regeneration (Nishioka et al., 2009; Xin et al., 2013). When the cytoplasmic Hippo kinase module is definitely on, MST1/2 activates LATS1/2, which in turn phosphorylates and inactivates YAP/TAZ. Phosphorylated YAP/TAZ are either retained in the cytoplasm via 14-3-3 connection or subjected to proteasomal or autophagy-induced degradation, and consequently, TEAD-mediated gene transcription is definitely suppressed. By contrast, when the Hippo kinases are inactive, dephosphorylated YAP/TAZ maneuver into the nucleus and induce TEAD target gene manifestation (Meng et al., 2016). With this view, it is well approved that the core Hippo kinases are tumor suppressors and users of the transcriptional module are oncogenes (Fig. 1). Moreover, even though function of TEAD is largely controlled by YAP/TAZ IQ-1S (Zhao et al., 2008a), recent studies uncover the Hippo-YAP-independent regulatory mechanisms of TEAD that include post-translational modifications and changes in subcellular localization (Chan et al., 2016; Lin et al., 2017; Noland et al., 2016). Open in a separate windowpane Fig. 1 Rules of YAP and TAZ from the Hippo pathwayThe core inhibitory kinase module of the Hippo pathway is composed of MST1/2, MAP4K, and LATS1/2. The transcriptional module is composed of YAP/TAZ and TEAD. (A) When the Hippo pathway is definitely off, YAP/TAZ are dephosphorylated, accumulated, and they translocate into the nucleus to bind the transcription factors, TEAD1CTEAD4, which enable target gene transcription involved in cell proliferation. (B) When the Hippo pathway is definitely turned on, LATS1/2 directly phosphorylate YAP/TAZ, which inhibit nuclear import of YAP/TAZ via 14-3-3-mediated cytoplasmic retention, and ubiquitination-mediated proteasomal and autolysosomal degradation. TEAD transcriptional activity is definitely suppressed by VGLL4. LATS shows large tumor suppressor; MST, mammalian STE20-like protein kinase; YAP, Yes-associated protein; TAZ, transcriptional co-activator with PDZ-binding motif; TEAD, TEA website family members; VGLL4, transcription cofactor vestigial-like protein 4. UPSTREAM SIGNALS OF THE HIPPO PATHWAY Hippo pathway and soluble factors G protein-coupled receptor (GPCR) Ligands The G protein-coupled receptors (GPCRs) and its ligands, such as mitogenic hormones and growth factors, were found out as the 1st soluble signals that regulate the Hippo pathway. YAP/TAZ are triggered through G12/13-coupled GPCR ligands, including lysophosphatidic acid (LPA), sphingosine-1-phosphate (S1P), Wnt3a, Wnt5a/b, thrombin, thromboxane A2, as well as Kaposi sarcoma-associated herpesvirus (Feng et al., 2016; Liu et al., 2015; Miller et al., 2012; Mo et al., 2012; Park et al., 2015; Yu et al., 2012). G12/13 inhibits LATS1/2 and activates YAP/TAZ via Rho GTPase-dependent actin polymerization. Gq/11-coupled GPCR ligands, such as endothelin-1 and estrogen also activate YAP/TAZ (Wang et al., 2017; Zhou et al., 2015). Moreover, constitutively triggered YAP/TAZ are oncogenic drivers and therapeutic focuses on in individuals with uveal melanoma harboring hyperactive Gq/11 mutations.